As of the time of writing, Big Tree Pharmacy has grown to 380 stores, with annual revenue expected to reach NT$17 billion. The company has set a goal of expanding to 500 stores by 2025, aiming to solidify its position as the leading pharmacy chain in Taiwan. In fact, the combined revenue of several other listed competitors still does not surpass Big Tree’s. The author outlines four key points that influenced the decision to invest in Big Tree Pharmacy at the time.
- Evaluate the industry size and growth potential: Is it a continuously growing sector?
- Assess the players within the industry and the competitive landscape.
- Determine whether Big Tree Pharmacy has a unique competitive advantage that could disrupt or reshape the current industry structure.
- Identify what resources Big Tree Pharmacy was lacking at the time to achieve its larger ambitions—and whether those are resources that a venture capital (VC) firm could provide.
Look at the article: https://pse.is/7e6kbn
